Difference between revisions of "Spironolactone bodies"
Jump to navigation
Jump to search
(create) |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
'''Spironolactone bodies''' are seen in the context of long-term spironolcatone use. | '''Spironolactone bodies''' are seen in the cortex of the [[adrenal gland]] in the context of long-term spironolcatone use. | ||
==General== | ==General== | ||
| Line 6: | Line 6: | ||
Note: | Note: | ||
* | *Aldosterone antagonist. | ||
*Commonly used anti-hypertensive medication.<ref name=pmid25108298>{{Cite journal | last1 = Patel | first1 = KA. | last2 = Calomeni | first2 = EP. | last3 = Nadasdy | first3 = T. | last4 = Zynger | first4 = DL. | title = Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings. | journal = Diagn Pathol | volume = 9 | issue = 1 | pages = 147 | month = Aug | year = 2014 | doi = 10.1186/1746-1596-9-147 | PMID = 25108298 }}</ref> | |||
*May be used to treat hypertension due to primary hyperaldosteronism related to adrenal pathology (nodular cortical hyperplasia or adenoma). | |||
*Other uses include treatment of adult acne harnessing an antiandrogenic activity. | |||
==Microscopic== | ==Microscopic== | ||
| Line 17: | Line 20: | ||
Image:Spironolactone_bodies_high_mag.jpg | SB - high mag. (WC/Nephron) | Image:Spironolactone_bodies_high_mag.jpg | SB - high mag. (WC/Nephron) | ||
Image:Spironolactone_bodies.png | SB (circled) - cropped high mag. (WC/Nephron) | Image:Spironolactone_bodies.png | SB (circled) - cropped high mag. (WC/Nephron) | ||
Image:Adrenal CorticalAdenoma SpironolactoneBodies MP PA.JPG|Adrenal Cortical Adenoma - Spironolactone Bodies (SKB) | |||
Image:Adrenal HyperplasticNodule SpironolactoneBodies MP PA.JPG|Adrenal Nodular Hyperplasia - Spironolactone Bodies (SKB) | |||
</gallery> | </gallery> | ||
==See also== | ==See also== | ||
*[[Adrenal gland]]. | *[[Adrenal gland]]. | ||
*[[Drug reaction]]. | |||
==References== | ==References== | ||
Latest revision as of 11:59, 5 March 2015
Spironolactone bodies are seen in the cortex of the adrenal gland in the context of long-term spironolcatone use.
General
Etiology:
- Long-term use of spironolactone.
Note:
- Aldosterone antagonist.
- Commonly used anti-hypertensive medication.[1]
- May be used to treat hypertension due to primary hyperaldosteronism related to adrenal pathology (nodular cortical hyperplasia or adenoma).
- Other uses include treatment of adult acne harnessing an antiandrogenic activity.
Microscopic
Features:[2]
- Location: zona glomerulosa (where aldosterone is produced).
- Appearance: eosinophilic spherical laminated whorls.
Images
SB - high mag. (WC/Nephron)
SB (circled) - cropped high mag. (WC/Nephron)
Adrenal Cortical Adenoma - Spironolactone Bodies (SKB)
Adrenal Nodular Hyperplasia - Spironolactone Bodies (SKB)
See also
References
- ↑ Patel, KA.; Calomeni, EP.; Nadasdy, T.; Zynger, DL. (Aug 2014). "Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.". Diagn Pathol 9 (1): 147. doi:10.1186/1746-1596-9-147. PMID 25108298.
- ↑ Kovacs K, Horvath E, Singer W (December 1973). "Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortex". J. Clin. Pathol. 26 (12): 949-57. PMC 477936. PMID 4131694. http://jcp.bmj.com/cgi/pmidlookup?view=long&pmid=4131694.